logo_new@0,75x

logo_new@0,75x

glycotest

All the posts published.

Six new patents protecting Glycotest’s HCC Panel test have been issued or allowed in the United States, Europe, China, Taiwan, Japan, and Mexico.

March 1, 2023

-

Posted by glycotest

Glycotest’s Patent Portfolio Covering Detection of Serious Liver Disease Expanded by Grant of European Patent.

January 13, 2021

-

Posted by glycotest

More than 50 Glycotest Fucosylated Biomarkers Protected through Grant of New US Patent.

November 3, 2020

-

Posted by glycotest

Japanese Patent Further Extends Coverage for Glycotest’s Serious Liver Disease Diagnostic Technology in Asia.

July 31, 2019

-

Posted by glycotest

Glycotest’s Coverage of Key Biomarker Fucosylated Kininogen Extended by European Patent.

July 24, 2019

-

Posted by glycotest

Glycotest’s Patent Portfolio Covering Important Asian Liver Disease Diagnostic Market Grows through Grant of Hong Kong Patent.

June 19, 2019

-

Posted by glycotest

Glycotest Announces Start of Enrollment in Its Case-Control Study of the HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma (NCT03878550).

June 13, 2019

-

Posted by glycotest

Glycotest Receives Additional US Patent Protection for Its Test for Liver Fibrosis-Cirrhosis.

January 15, 2019

-

Posted by glycotest

Glycotest’s Coverage of Key Biomarker Fucosylated Kininogen Extended by Canadian Patent

December 4, 2018

-

Posted by glycotest

Glycotest™ Closes $10 Million Series A Financing with Fosun Pharma

October 22, 2018

-

New York, NY—October 22, 2018. Glycotest Inc., Inc., a diagnostics company commercializing new and unique blood tests for life threatening liver cancers…

Posted by glycotest

Glycotest Announces Grant of US Patent Extending Coverage of Its Fucosylated Biomarker Diagnostic Technology for Serious Liver Disease

September 25, 2018

-

Posted by glycotest

Glycotest Innovator Joins the Medical University of South Carolina as the New SmartState Endowed Chair of Proteomic Biomarkers

September 27, 2016

-

New York, NY—September 27, 2016 — Glycotest, Inc. innovator Professor Anand Mehta, a leader in the development of glycoproteomic technologies for the…

Posted by glycotest

Glycotest Intellectual Property Portfolio Strengthened by Grant of Japanese Patent

September 12, 2016

-

New York, NY—September 12, 2016—Glycotest Inc., announced today that a Japanese patent has been granted that provides important protection of the Company’s…

Posted by glycotest

Dr. Timothy Block, President, Baruch S. Blumberg Institute and the Hepatitis B Foundation, in a video on the Glycotest Technology

June 22, 2016

-

Posted by glycotest

Lawrence Cohen, CEO of Glycotest, presented at Net Scientific’s June 2016 Capital Markets Day.

June 22, 2016

-

Posted by glycotest

Lawrence Cohen, CEO of Glycotest, will be presenting the company at the New York Venture Summit on July 21, 2016.

June 8, 2016

-

Posted by glycotest

NetScientific portfolio company, Glycotest Inc., appoints world leading medical advisory board chaired by David Chernoff, M.D.

January 6, 2016

-

Posted by glycotest

NetScientific appoints diagnostics leader Lawrence Cohen as CEO of Glycotest Inc.

December 16, 2015

-

Posted by glycotest

NetScientific’s subsidiary, Glycotest Begins a New Research Collaboration with Oncimmune

October 3, 2014

-

Posted by glycotest

LOAD MORE POSTS

GET IN TOUCH

Give Us A Call

+1 484-431-3483

Send Us A Message

info@glycotest.com

Copyright© All Rights Reserved

Website Designed & Developed by Jason and Company

glycotest | Glycotest Diagnostics